BMJ  2006;332:277-278 (4 February), doi:10.1136/bmj.332.7536.277-a

Commentary

Challenge for doctors and policy makers

Paul Haber, head of department of drug and alcohol services1

1 Royal Prince Alfred Hospital, NSW 2050, Australia phaber@mail.usyd.edu.au

The first 150 words of the full text of this article appear below.

Mr Bond's management raises several issues.1 In the rapid responses on bmj.com, Mark Willenbring succinctly summarises the most practical approach to the management of Mr Bond's alcohol dependence.2 Regular follow-up with feedback on progress and continuing encouragement to reduce alcohol use can be surprisingly effective. It is also a straightforward management plan that can be offered by the patient's current medical team. Cirrhotic patients can safely be offered treatment to control their alcohol use with acamprosate, naltrexone, or disulfiram, singly or in combination.3 These drugs are simpler to prescribe and monitor than many used in routine clinical practice and do not have to be given by addiction specialists. Colin Brewer correctly notes that the oldest of these, disulfiram, may be the most effective if administration is supervised by a community nurse or family member.2 However, unsupervised disulfiram is ineffective.

Is there any specific medical therapy for progressive alcoholic liver . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

An alcoholic patient who continues to drink: case outcome
Stuart McPherson and Colin John Rees
BMJ 2006 332: 276. [Extract] [Full Text] [PDF]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ